BNTX vs HALO: stock comparison and AI forecast
Biontech Se (BNTX) and Halozyme Therapeutics, Inc. (HALO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BNTX Biontech Se
- Market Cap
- $21.71B
- P/E Ratio
- 2.2x
- Size
- large-cap
- AI Forecast
HALO Halozyme Therapeutics, Inc.
- Market Cap
- $13.96B
- P/E Ratio
- 24.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BNTX is 1.6 times larger than HALO by market capitalization ($21.71B against $13.96B).
- BNTX trades at 2.2 times trailing earnings, HALO at 24.9 times.
- BNTX turns 32.0% of its revenue into net income, against 26.9% for HALO.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BNTX | HALO |
|---|---|---|
| Market Cap | $21.71B | $13.96B |
| P/E Ratio | 2.22x | 24.94x |
| EPS | $38.67 | $4.93 |
| Revenue/Share | $119.85 | $15.88 |
| FCF/Share | $83.21 | $7.81 |
Profitability & Margins
| Metric | BNTX | HALO |
|---|---|---|
| ROE | 44.5% | – |
| ROA | 38.9% | 14.0% |
| ROIC | 53.5% | 22.5% |
| Gross Margin | 82.1% | 82.3% |
| Operating Margin | 39.7% | 37.4% |
| Net Margin | 32.0% | 26.9% |
| EBT Margin | 46.4% | 36.3% |
| Tax Rate | 31.0% | 25.9% |
Financial Health
| Metric | BNTX | HALO |
|---|---|---|
| Current Ratio | 7.54x | 3.88x |
| Quick Ratio | 7.49x | 3.60x |
| D/E Ratio | 0.14x | – |
| Financial Leverage | 1.14x | – |
| Working Capital | $16.45B | $1.37B |
Cash Flow
| Metric | BNTX | HALO |
|---|---|---|
| Operating Cash Flow | $22.22B | $898M |
| Free Cash Flow | $21.04B | $886M |
| Capital Spending | -$1.18B | -$12M |
| OCF Growth YoY | – | 47.0% |
| FCF Growth YoY | 0.0% | 47.1% |
| FCF/Sales | 69.4% | 49.1% |
| CapEx/Sales | 3.9% | 0.7% |
Operational Efficiency
| Metric | BNTX | HALO |
|---|---|---|
| Asset Turnover | 1.22x | 0.52x |
| Receivables Turnover | 28.9x | 3.5x |
| Inventory Turnover | 43.2x | 2.4x |
| Fixed Assets Turnover | 24.8x | 35.2x |
| Days Sales Outstanding | 13 days | 105 days |
| Days Inventory | 8 days | 151 days |
| Payables Period | 41 days | 38 days |
| Cash Conversion Cycle | -20 days | 218 days |
Income Statement
| Metric | BNTX | HALO |
|---|---|---|
| Total Revenue | $30.31B | $1.80B |
| Operating Income | $12.03B | $674M |
| Net Income | $9.70B | $485M |
| R&D Expense | $8.70B | $113M |
| SG&A Expense | – | $250M |
| Cost of Goods Sold | $5.41B | $320M |
Dividend & Shareholder Information
| Metric | BNTX | HALO |
|---|---|---|
| Shares Outstanding | 253M | 114M |
| Net Income Growth | – | -18.5% |
| EPS Growth | – | 11.5% |
BNTX vs HALO: stock comparison and AI forecast
Which is bigger, BNTX or HALO?
BNTX is 1.6 times larger than HALO by market capitalization ($21.71B against $13.96B).
Which is cheaper on earnings, BNTX or HALO?
BNTX trades at 2.2 times trailing earnings, HALO at 24.9 times.
Which one does Intratio's AI model rank higher, BNTX or HALO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.